http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20030002680-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7a98c45339d7b16906e4f4b4d59b263a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7032
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
filingDate 2001-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e40e5d6c39ffba4319c7a200f8e71ca1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_198456d15fe1eda9cddd80c36d69d5b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c5d227d7df7edfb9e0d8fb7c364d887
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5bfa3dc745702799d3d68a0c0083a7ca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7aa4fba5891ab7cb198970cb2959994f
publicationDate 2003-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20030002680-A
titleOfInvention Lectin-conjugated ellagitannin inhibiting growth and metastasis of melanoma cell
abstract The present invention relates to a combination of a protein and a compound having cancer cell growth inhibition and metastasis inhibiting activity, and more particularly, a lectin having a function of selectively recognizing melanoma cells and an ellagitannin having a function of destroying cancer cells. The present invention relates to a combination of lectin and ellagitannin, which can be used as a therapeutic agent to inhibit metastasis caused by melanoma.n n n The lectin and ellagitannin conjugates according to the present invention can be effectively used as anticancer agents for melanoma because they can specifically recognize melanoma and inhibit the growth and metastasis of melanoma cells.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023053082-A1
priorityDate 2001-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24139
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID159557814
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439197
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554054
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1580004
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281855
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426385502
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID4565
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547110
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID370
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546193
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22833652
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407377111
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445063
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422601151
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152771881
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1580004
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422602877
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID4565
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5250894
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163606
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419572068
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16132398
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419588330
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426064243
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450838065
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID59272

Total number of triples: 45.